PubRank

Archana Monie

Author PubWeight™ 31.71‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Pretreatment with cisplatin enhances E7-specific CD8+ T-Cell-mediated antitumor immunity induced by DNA vaccination. Clin Cancer Res 2008 1.29
2 Therapeutic human papillomavirus vaccines: current clinical trials and future directions. Expert Opin Biol Ther 2008 1.24
3 Immunotherapy for cervical cancer: Research status and clinical potential. BioDrugs 2010 1.18
4 Generation and characterization of a preventive and therapeutic HPV DNA vaccine. Vaccine 2007 1.12
5 Treatment with proteasome inhibitor bortezomib enhances antigen-specific CD8+ T-cell-mediated antitumor immunity induced by DNA vaccination. J Mol Med (Berl) 2008 1.04
6 Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts. Cancer Immunol Immunother 2008 1.04
7 DNA vaccines for cervical cancer: from bench to bedside. Exp Mol Med 2007 1.02
8 Enhancing the therapeutic effect against ovarian cancer through a combination of viral oncolysis and antigen-specific immunotherapy. Mol Ther 2010 1.01
9 Ectopic expression of X-linked lymphocyte-regulated protein pM1 renders tumor cells resistant to antitumor immunity. Cancer Res 2010 0.99
10 In vivo microRNA-155 expression influences antigen-specific T cell-mediated immune responses generated by DNA vaccination. Cell Biosci 2011 0.97
11 Molecular epidemiology of human papillomavirus. J Formos Med Assoc 2008 0.97
12 Control of cervicovaginal HPV-16 E7-expressing tumors by the combination of therapeutic HPV vaccination and vascular disrupting agents. Hum Gene Ther 2011 0.96
13 Antigen-specific immunotherapy of cervical and ovarian cancer. Immunol Rev 2008 0.96
14 Expression of IL-15RA or an IL-15/IL-15RA fusion on CD8+ T cells modifies adoptively transferred T-cell function in cis. Eur J Immunol 2009 0.94
15 Enhancing therapeutic HPV DNA vaccine potency through depletion of CD4+CD25+ T regulatory cells. Vaccine 2008 0.94
16 Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer. Hum Gene Ther 2009 0.91
17 The impact of preventive HPV vaccination. Discov Med 2006 0.91
18 Combination of treatment with death receptor 5-specific antibody with therapeutic HPV DNA vaccination generates enhanced therapeutic anti-tumor effects. Vaccine 2008 0.90
19 Treatment with imiquimod enhances antitumor immunity induced by therapeutic HPV DNA vaccination. J Biomed Sci 2010 0.89
20 DNA vaccines for cervical cancer. Am J Transl Res 2010 0.88
21 Combination of viral oncolysis and tumor-specific immunity to control established tumors. Clin Cancer Res 2009 0.88
22 Combination of apigenin treatment with therapeutic HPV DNA vaccination generates enhanced therapeutic antitumor effects. J Biomed Sci 2009 0.88
23 DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity. Immunol Lett 2007 0.87
24 Treatment with demethylating agent, 5-aza-2'-deoxycytidine enhances therapeutic HPV DNA vaccine potency. Vaccine 2009 0.86
25 Opportunities to improve the prevention and treatment of cervical cancer. Curr Mol Med 2007 0.86
26 Enhancement of DNA vaccine potency through coadministration of CIITA DNA with DNA vaccines via gene gun. J Immunol 2008 0.85
27 Improving therapeutic HPV peptide-based vaccine potency by enhancing CD4+ T help and dendritic cell activation. J Biomed Sci 2010 0.85
28 Vascular disrupting agent DMXAA enhances the antitumor effects generated by therapeutic HPV DNA vaccines. J Biomed Sci 2011 0.84
29 Inhibition of tumor growth by NK1.1+ cells and CD8+ T cells activated by IL-15 through receptor beta/common gamma signaling in trans. J Immunol 2008 0.83
30 Delivery of chemotherapeutic agents using drug-loaded irradiated tumor cells to treat murine ovarian tumors. J Biomed Sci 2010 0.83
31 alpha-Galactosylceramide enhances the protective and therapeutic effects of tumor cell based vaccines for ovarian tumors. Vaccine 2008 0.82
32 Carrageenan as an adjuvant to enhance peptide-based vaccine potency. Vaccine 2010 0.82
33 Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection. Vaccine 2010 0.80
34 Intraperitoneal administration of poly(I:C) with polyethylenimine leads to significant antitumor immunity against murine ovarian tumors. Cancer Immunol Immunother 2011 0.79